CYSTEINYL MATRAXETAN

Details

Stereochemistry	EPIMERIC
Molecular Formula	C25H41N7O11S
Molecular Weight	647.698
Optical Activity	UNSPECIFIED
Defined Stereocenters	1 / 2
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

N[C@@H](CSC1CC(=O)N(CCNC(=O)CN2CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC2)C1=O)C(O)=O

InChI

InChIKey=YDVAVGNOTNACMN-ZENAZSQFSA-N

InChI=1S/C25H41N7O11S/c26-17(25(42)43)16-44-18-11-20(34)32(24(18)41)2-1-27-19(33)12-28-3-5-29(13-21(35)36)7-9-31(15-23(39)40)10-8-30(6-4-28)14-22(37)38/h17-18H,1-16,26H2,(H,27,33)(H,35,36)(H,37,38)(H,39,40)(H,42,43)/t17-,18?/m0/s1

HIDE SMILES / InChI

Molecular Formula	C25H41N7O11S
Molecular Weight	647.698
Charge	0
Count

Stereochemistry	EPIMERIC
Additional Stereochemistry	No
Defined Stereocenters	1 / 2
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

Substance Class	Chemical Created by `admin` on `Sat Dec 16 15:19:11 GMT 2023` Edited by `admin` on `Sat Dec 16 15:19:11 GMT 2023`
Record UNII	BXP1626G1T
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

CYSTEINYL MATRAXETAN

Common Name

English

(3RS)-2,5-DIOXO-1-(2-(2-(4,7,10-TRIS(CARBOXYMETHYL)-1,4,7,10-TETRAAZACYCLODODECAN-1-YL)ACETAMIDO)ETHYL)PYRROLIDIN-3-YL-CYSTEINE

Common Name

English

Code System Code Type Description

FDA UNII

BXP1626G1T

Created by admin on Sat Dec 16 15:19:11 GMT 2023 , Edited by admin on Sat Dec 16 15:19:11 GMT 2023

PRIMARY

PUBCHEM

165412020

Created by admin on Sat Dec 16 15:19:11 GMT 2023 , Edited by admin on Sat Dec 16 15:19:11 GMT 2023

PRIMARY